# Smiths Medical expands syringe production capacity in Keene, New Hampshire

Smiths Medical partnered with BARDA and the Department of Defense to expand capacity at its Keene, New Hampshire facility for production of hypodermic needle and syringe products. BARDA will invest $20 million into a $38 million capital expansion project, increasing needle production capacity by 125 million units per year.

- Type: Expansion
- Announced: 2020-07-15
- Where: Keene, New Hampshire, United States
- Value: $38.0M
- Status: announced
- Capacity: 125 million units per year
- Products: integrated hypodermic needle and syringe products, EDGE Safety Hypodermic Devices, Needle-Pro EDGE hypodermic needle
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Smiths Medical](https://endata.com/companies/46970.md)
- [Biomedical Advanced Research and Development Authority (BARDA)](https://endata.com/companies/48590.md) (investor)
- [Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND)](https://endata.com/companies/48591.md) (partner)

## Sources

- [biospace.com](https://www.biospace.com/smiths-medical-partners-with-u-s-government-on-covid-19-vaccine-efforts), 2020-07-15: "BARDA, in collaboration with JPEO-CBRND, will invest $20 million into a $38 million capital expansion project to further expand Smiths Medical's production operations in Keene, New Hampshire."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.